| MHC | Major Histocompatibility Complex |
|---|---|
| EMM | erythema multiforme major |
| HMC | hand-mirror cell; health maintenance cooperative; heroin, morphine, and cocaine; histocompatibility ... |
| MAD | major affective disorder; mandibulo-acral dysplasia; maximum allowable dose; methylandrostenediol; m... |
| MAKA | major karyotypic abnormality |
| filling defect | Displacement of contrast medium by a space-occupying lesion in a radiographic study of a contrast-filled hollow viscus, such as a polyp on a barium enema; also applied to defects in the otherwise uniform distribution of radionuclide in an organ, such as a metastasis in the liver on a 99mTc-sulfur colloid scan. (05 Mar 2000) |
|---|---|
| filling defect in renal collecting system | <radiology> Common causes: transitional cell carcinoma, blood clot, lucent calculus (urate) less common causes: fungus ball, sloughed papilla, fibroepithelial polyp, invasion by hypernephroma, malakoplakia, vessel impression, metastases (12 Dec 1998) |
| lambdoid suture defect | <radiology> Well-defined lucent lesion, classically unilateral, associated with neurofibromatosis (12 Dec 1998) |
| luteal phase defect | Inadequate function of the corpus luteum that may prevent a fertilized egg from implanting in the uterus or may lead to early pregnancy loss. (09 Oct 1997) |
| adeno-associated virus | <virology> A genus of viruses in the family Parvoviridae which are all defective viruses (unable to replicate by themselves) and depend on the co-infection of their host cell by other, nondefective viruses to help them replicate. (09 Oct 1997) |
| aids-associated nephropathy | Renal syndrome in human immunodeficiency virus-infected patients characterised by nephrotic syndrome, severe proteinuria, focal and segmental glomerulosclerosis with distinctive tubular and interstitial changes, enlarged kidneys, and peculiar tubuloreticular structures. The syndrome is distinct from heroin-associated nephropathy as well as other forms of kidney disease seen in HIV-infected patients. (12 Dec 1998) |
| antigens, tumour-associated, carbohydrate | Carbohydrate antigens expressed by malignant tissue. They are useful as tumour markers and are measured in the serum by means of a radioimmunoassay employing monoclonal antibodies. (12 Dec 1998) |
| associated | Joined as a companion; brought into association; accompanying; combined. <physiology> Associated movements, consensual movements which accompany voluntary efforts without our consciousness. Source: Websters Dictionary (01 Mar 1998) |
| associated antagonist | One of two muscles or groups of muscles which pull in nearly opposite directions, but which, when acting together, move the part in a path between their diverging lines of action. (05 Mar 2000) |
| associated macrophage | A mature macrophage in an active metabolic state that is cytotoxic to tumour/target cells, usually following exposure to certain cytokines. (05 Mar 2000) |
| associated movements | Normal involuntary limp movements that accompany voluntary movement, e.g., arm swing with walking. (05 Mar 2000) |
| p60 tumour necrosis factor receptor-associated kinase | <enzyme> Interacts with and causes phosphorylation of the cytoplasmic domain of the tnf receptor Registry number: EC 2.7.10.- Synonym: p60 tnf receptor-associated kinase, p60-trak (26 Jun 1999) |
| GAK, cyclin G-associated kinase | <chemical> Has a ser/thr protein kinase-like catalytic domain at the n-terminal; contains a tensin/auxilin-like domain; genbank d38560 Synonym: gak protein (26 Jun 1999) |
| Varciella-Zoster ORF47-associated protein kinase | <enzyme> Catalyses the in vitro phosphorylation of the vzv orf62 protein Registry number: EC 2.7.1.- Synonym: vzv orf47-apk (26 Jun 1999) |
| matrix-associated helicase | <enzyme> Component of the pre-mRNA splicing complex; has atpase activity and DNA helicase activity on a partially double-stranded DNA substrate in the 3'-5' direction Registry number: EC 2.7.7.- Synonym: helicase mah (26 Jun 1999) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|